chr8-122952199-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014943.5(ZHX2):c.689G>A(p.Gly230Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014943.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZHX2 | NM_014943.5 | c.689G>A | p.Gly230Asp | missense_variant | 3/4 | ENST00000314393.6 | NP_055758.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZHX2 | ENST00000314393.6 | c.689G>A | p.Gly230Asp | missense_variant | 3/4 | 1 | NM_014943.5 | ENSP00000314709 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000528 AC: 8AN: 151462Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251340Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135848
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461826Hom.: 0 Cov.: 87 AF XY: 0.0000179 AC XY: 13AN XY: 727208
GnomAD4 genome AF: 0.0000528 AC: 8AN: 151462Hom.: 0 Cov.: 31 AF XY: 0.0000677 AC XY: 5AN XY: 73892
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2023 | The c.689G>A (p.G230D) alteration is located in exon 3 (coding exon 1) of the ZHX2 gene. This alteration results from a G to A substitution at nucleotide position 689, causing the glycine (G) at amino acid position 230 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at